Dr Lim Yujing, EXECUTIVE DIRECTOR, CHIEF EXECUTIVE OFFICER, CHIEF TECHNOLOGY OFFICER OSTEOPORE
Dr. Lim holds a PhD from Nanyang Technological University, Singapore. Prior to joining Osteopore, Dr. Lim conducted research on biomaterials for tissue engineering and regenerative medicine, and developed material fabrication platforms. Dr. Lim published 14 articles in internationally peer-reviewed journals in that time. Dr. Lim joined Osteopore in December 2014, and has led Osteopore to important regulatory and quality milestones. In addition, Dr. Lim led the expansion of product and therapy portfolio, and contributed to the improvement in manufacturing efficiency.
- Osteopore (OSX:ASX), Press Release (OSX.AX)
Osteopore Honoured with Distinction Award in Leadership for Good
Osteopore is honoured to receive the Distinction Award in the Leadership for Good category at the 10th anniversary of Brands For Good.
1 minute read
- Osteopore (OSX:ASX), Tech
Bringing 3D printing to the next level for sustainable healing
Three dimensional or “3D printing” is an additive manufacturing process that has been around for...
3 minute read
Top Posts
- In-vitro vs in-situ tissue engineering. What are the differences?
- Regrowing Damaged Body Parts: How One Australian-listed Company is Making it Accessible
- The Suzhou Industrial Park and Collaboration
- Bringing 3D printing to the next level for sustainable healing
- What are bioresorbable implants and why Osteopore is committed to them